Last updated 2026-06-18
Portfolio
2
in our dataset
Rounds participated
2
Rounds led
0
Rounds' value
$398.0M
total disclosed, rounds participated
Stages
—
Portfolio · 2
Investment activity
1 portfolio exit on record.
Portfolio by sector
Health Tech & Life Sciences1
Cyber Security1
Q&A
- What is XT Investments' most significant exit?
- XT Investments achieved a significant exit in March 2020 with the acquisition of Checkmarx by Hellman & Friedman for $1.15 billion.
- Which sectors does XT Investments focus on?
- XT Investments has shown a focus on the Health Tech & Life Sciences and Cyber Security sectors, with portfolio companies in both.
- Can you name some of XT Investments' notable portfolio companies?
- XT Investments' portfolio includes Angioslide, which develops embolic capture angioplasty devices, and Checkmarx, a cloud-native AppSec platform that was acquired in 2020.
- What is the typical investment range for XT Investments?
- XT Investments typically invests in the range of $3 million to $8.25 million.
- When did XT Investments make its most recent investment according to available data?
- XT Investments made an investment in May 2015, which was a D Round.
- What funding stages has XT Investments participated in?
- XT Investments has participated in various funding stages, including B Round, C Round, D Round, and E Round.